D-1446-2020 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-1446-2020 was initiated by Pfizer Inc. on Jul 20, 2020 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; potential loose metal overseal crimp defects. The recall status is terminated (terminated Dec 8, 2022). Affected quantity: 19,144 vials.

Recall details

Product Type
Drugs
Report Date
Aug 12, 2020
Initiation Date
Jul 20, 2020
Termination Date
Dec 8, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,144 vials

Product description

Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12

Reason for recall

Lack of Assurance of Sterility; potential loose metal overseal crimp defects.

Distribution pattern

United States including Puerto Rico

Code information

Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1446-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1446-2020. Report a data issue: hello@regdatalab.com.